Skip to main navigation Skip to search Skip to main content

Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control

  • the MASK Study Group
  • CHU Montpellier
  • Pierre Louis Institute of Epidemiology and Public Health
  • Kyomed
  • MedScript Ltd
  • MACVIA-France
  • Charité – Universitätsmedizin Berlin
  • Global Allergy and Asthma European Network (GALEN)
  • Peercode DV
  • Academic Medical Centre
  • University of Porto
  • CUF Porto Instituto & Hospital
  • Hospital District of Helsinki and Uusimaa
  • University of Würzburg
  • Barlicki University Hospital
  • University of Barcelona
  • University of Manchester
  • National and Kapodistrian University of Athens
  • S. Martino Policlinic Hospital
  • Medical University of Warsaw
  • Medical University of Graz
  • Vilnius University
  • Sachs’ Children and Youth Hospital
  • Karolinska Institutet
  • VIMA: Ageing and chronic diseases Epidemiological and public health approaches
  • Université Paris-Saclay

Research output: Contribution to journalArticlepeer-review

83 Scopus citations

Abstract

Background: Visual Analogue Scale (VAS) is a validated tool to assess control in allergic rhinitis patients. Objective: The aim of this study was to validate the use of VAS in the MASK-rhinitis (MACVIA-ARIA Sentinel NetworK for allergic rhinitis) app (Allergy Diary) on smartphones screens to evaluate allergic rhinitis symptoms and disease control. Methods: Each user filled 4 different VAS measuring overall, nasal, ocular, and asthma symptoms at least once. Following COSMIN guidelines, we evaluated internal consistency, (Cronbach's alpha coefficient and test-retest), reliability (intraclass correlation coefficients), sensitivity, and acceptability of the MASK-Rhinitis VAS. Results: Between 1 August 2015 and 31 July 2016, the app was used 14 612 times in 15 countries. A total of 1225 users used it more than once, during the evaluated period. The tool resulted to be statistically satisfactory, showing excellent internal consistency (Cronbach's test > 0.84, test-retest > 0.7), reliability (>0.9), and acceptability. In addition, the tool had a good sensitivity when users (n = 521) answered the VAS twice in less than 3 hours. Conclusions and Clinical Relevance: The MASK-rhinitis VAS is a reliable and valid tool to assess allergic control on smartphone screens, at the population level.

Original languageEnglish
Pages (from-to)1526-1533
Number of pages8
JournalClinical and Experimental Allergy
Volume47
Issue number12
DOIs
StatePublished - Dec 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • MASK
  • allergic rhinitis
  • allergy
  • control
  • visual analogue scale

Fingerprint

Dive into the research topics of 'Validation of the MASK-rhinitis visual analogue scale on smartphone screens to assess allergic rhinitis control'. Together they form a unique fingerprint.

Cite this